Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Total Debt (2016 - 2018)

Niagen Bioscience (NAGE) has disclosed Total Debt for 3 consecutive years, with $137000.0 as the latest value for Q4 2018.

  • Quarterly Total Debt fell 55.81% to $137000.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $137000.0 through Dec 2018, down 55.81% year-over-year, with the annual reading at $137000.0 for FY2018, 55.81% down from the prior year.
  • Total Debt for Q4 2018 was $137000.0 at Niagen Bioscience, down from $310000.0 in the prior quarter.
  • The five-year high for Total Debt was $4.9 million in Q1 2016, with the low at $137000.0 in Q4 2018.
  • Average Total Debt over 3 years is $1.4 million, with a median of $327000.0 recorded in 2016.
  • The sharpest move saw Total Debt crashed 92.94% in 2016, then fell 9.88% in 2017.
  • Over 3 years, Total Debt stood at $344000.0 in 2016, then decreased by 9.88% to $310000.0 in 2017, then tumbled by 55.81% to $137000.0 in 2018.
  • According to Business Quant data, Total Debt over the past three periods came in at $137000.0, $310000.0, and $344000.0 for Q4 2018, Q4 2017, and Q4 2016 respectively.